Mingfeng Han

6.8k citations
36 papers · 5.2k · 3 hit papers · h-index 15

Impact in

Papers in

Mingfeng Han

30 papers receiving 5k citations

Mingfeng Han's Hit Papers

Effective treatment of severe COVID-19 patients with tocilizumab 2020 · 2.1k citations
2.1k0+2+4Years since publication5001k1.5k2k

Peers

Mingfeng Han
Comparison fields: 5 of 143
  • Infectious Diseases 3.6k
  • Complementary and alternative medicine 237
  • Clinical Psychology 493
  • General Dentistry 7
  • Modeling and Simulation 60
Replace Fang Cheng with:
Fang Cheng China
Wen Liu China
Haojia Wang China
Jianxin Song China
Ming Wei China
Youqin Yan China
Lianhan Shang China
Jin‐Kui Yang China
Xing Zhou China
Mingfeng Han relative to Fang Cheng China Fang Cheng's profile →
Citations per field
00.5×2×3×4.0×
Fang Cheng · 1×
Citations per year

Countries citing papers authored by Mingfeng Han

Since Specialization
Citations

This map shows the geographic impact of Mingfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Han more than expected).

Fields of papers citing papers by Mingfeng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Han. The network helps show where Mingfeng Han may publish in the future.

Co-authors

The 25 scholars most cited alongside Mingfeng Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingfeng Han Line = papers co-authored together Mingfeng Han links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effective treatment of severe COVID-19 patients with tocilizumab
Hit paper breakdown →
20202107
2
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Hit paper breakdown →
2020867
3 2020786
4
[Mental health survey of medical staff in a tertiary infectious disease hospital for COVID-19].
Hit paper breakdown →
2020528
5 2020368
6 2020170
7 202165
8 202135
9 202025
10 201823
11 202022
12 202021
13 202018
14 202016
15 202015
16 202215
17 202113
18 202111
19 202110
20 20237

About Mingfeng Han

Mingfeng Han is a scholar working on Infectious Diseases, Complementary and alternative medicine, Pulmonary and Respiratory Medicine, Pharmacology and Pathology and Forensic Medicine, having authored 36 papers that have together received 5.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (18 papers), Medical Research and Treatments (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Whipple's Disease and Interleukins (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Artificial Intelligence in Healthcare and Education (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Infectious Diseases (3.6k citations), Complementary and alternative medicine (237 citations), Clinical Psychology (493 citations), General Dentistry (7 citations) and Modeling and Simulation (60 citations). Mingfeng Han has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiuyong Li, Wei Sun, Xiaoling Xu, Yun Yang, Aijun Pan, Dongsheng Wang, Tiantian Li, Xiaohu Zheng, Haiming Wei and Yonggang Zhou. Their work appears in journals such as Frontiers in Medicine, Phytomedicine, Aging, Journal of Inflammation Research and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact